Genpharmasec (BOM:531592) 3-Year EBITDA Growth Rate : -4.70% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Genpharmasec 3-Year EBITDA Growth Rate?

Genpharmasec's EBITDA per Share for the three months ended in Mar. 2024 was ₹0.01.

During the past 12 months, Genpharmasec's average EBITDA Per Share Growth Rate was 62.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Genpharmasec was 148.40% per year. The lowest was -65.10% per year. And the median was -13.95% per year.

Competitive Comparison of Genpharmasec's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Genpharmasec's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genpharmasec's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genpharmasec's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Genpharmasec's 3-Year EBITDA Growth Rate falls into.

Genpharmasec 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Genpharmasec (BOM:531592) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Genpharmasec 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Genpharmasec's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Genpharmasec (BOM:531592) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genpharmasec Ltd (BOM:531592) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Akurli Road, Office No. 104 and 105, 1st Floor, Gundecha Industrial Premises Co-op Soc. Ltd., Kandivali (East), Mumbai, MH, IND, 400101

Website

https://www.satellitecorporate.com

Genpharmasec Ltd formerly Generic Pharmasec Ltd is engaged in pharmaceutical activities and services. It operates in two reportable segments: Diagnostic Pharma Equipment which includes pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, and herbs, and in pharmaceutical, medicinal, and proprietary and industrial preparations, compounds and articles of kinds, chemists, druggists, and chemical manufacturers. Trading in the Securities segment invests in the secondary securities market. The Diagnostic Pharma Equipment segment is the key revenue generator for the group.

Genpharmasec (BOM:531592) Headlines

No Headlines